Amelioration of glucose homeostasis and visceral adiposity in metabolic syndrome by mild electrical current and thermo therapy

UMIN ID: UMIN000001149

Registered date:01/06/2008

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: metabolic syndrome
• Date of first enrollment: 2008/05/01
• Target sample size: 80
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

12 weeks of MET (4 times a week, 60 min each time), and then 12 weeks of withdrawal, 40 subjects.
12 weeks of no treatment, and then 12 weeks of MET (4 times a week, 60 min each time), 40 subjects.

Outcome(s)

• Primary Outcome: Changes of biomarkers related to metabolic syndrome at 12 weeks and 24 weeks after MET treatment.
• Secondary Outcome: General assessment of MET device evaluated by subjects.

Key inclusion & exclusion criteria

• Age minimum: 40years-old
• Age maximum: 65years-old
• Gender: Male
• Exclude criteria: i) Past history or current medication of myocardial infarction, angina, apoplexy and arteriosclerosis obliterans. ii)Severe wound, infections, pre- or post-operation. iii)Severe liver dysfunction (GOT and/or GPT: greater than 100U). iv)Chronic heart failure, familial dyslipidemia. v)Severe diabetic complications. vi)HbA1c : greater than or equal to 6.5%. vii)Pacemaker carrier.

Related Information

• Primary Sponsor: Department of Metabolic Medicine, Graduate School of Medical Sciences, Kumamoto University
• Secondary Sponsor: Japanese Red Cross Society, Kumamoto Health Care Center.
• Source(s) of Monetary Support: Department of Metabolic Medicine, Graduate School of Medical Sciences, Kumamoto University